Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the neuroprotective Wallerian degeneration slow (Wlds) gene

[1]  Kevin A. Robertson,et al.  Differential Proteomics Analysis of Synaptic Proteins Identifies Potential Cellular Targets and Protein Mediators of Synaptic Neuroprotection Conferred by the Slow Wallerian Degeneration (Wlds) Gene*S , 2007, Molecular & Cellular Proteomics.

[2]  M. Freeman,et al.  The Drosophila Cell Corpse Engulfment Receptor Draper Mediates Glial Clearance of Severed Axons , 2006, Neuron.

[3]  G. Arbuthnott,et al.  Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion. , 2006, Brain : a journal of neurology.

[4]  Kevin A. Robertson,et al.  The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. , 2006, Human molecular genetics.

[5]  J. Glass,et al.  The Wld S gene modestly prolongs survival in the SOD1G93A fALS mouse , 2005, Neurobiology of Disease.

[6]  R. Ribchester,et al.  A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses , 2005, The European journal of neuroscience.

[7]  Hitoshi Osaka,et al.  The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. , 2004, Brain : a journal of neurology.

[8]  Maria Ballester,et al.  Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals. , 2004, BioTechniques.

[9]  P. Aebischer,et al.  Wlds-Mediated Protection of Dopaminergic Fibers in an Animal Model of Parkinson Disease , 2004, Current Biology.

[10]  R. Ribchester,et al.  Neuroprotection after Transient Global Cerebral Ischemia in Wlds Mutant Mice , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  J. Sanes,et al.  Inhibiting Axon Degeneration and Synapse Loss Attenuates Apoptosis and Disease Progression in a Mouse Model of Motoneuron Disease , 2003, Current Biology.

[12]  C. Wessig,et al.  The Wlds Mutation Delays Robust Loss of Motor and Sensory Axons in a Genetic Model for Myelin-Related Axonopathy , 2003, The Journal of Neuroscience.

[13]  J. Glass,et al.  Wlds mice are resistant to paclitaxel (taxol) neuropathy , 2002, Annals of neurology.

[14]  R. Ribchester,et al.  Age‐Dependent Synapse Withdrawal at Axotomised Neuromuscular Junctions in Wlds Mutant and Ube4b/Nmnat Transgenic Mice , 2002, The Journal of physiology.

[15]  M. Coleman,et al.  Genotyping methods to detect a unique neuroprotective factor (Wld s) for axons , 2002, Journal of Neuroscience Methods.

[16]  M. Rich,et al.  The WldS protein protects against axonal degeneration: A model of gene therapy for peripheral neuropathy , 2001, Annals of neurology.

[17]  V. Perry,et al.  Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene , 2001, Nature Neuroscience.

[18]  V. Perry,et al.  A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  V. Perry,et al.  Persistence of Neuromuscular Junctions after Axotomy in Mice with Slow Wallerian Degeneration (C57BL/Wlds) , 1995, The European journal of neuroscience.

[20]  M. Rudnicki,et al.  Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.

[21]  V. Perry,et al.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve , 1989, The European journal of neuroscience.

[22]  B. Trapp,et al.  The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease , 2007, NeuroMolecular Medicine.